TrialBlood cancer journal2016

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma.

Y Jethava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.